Brent Sabatini
Svp, Chief Accounting Officer at Vir Biotechnology, Inc. (VIR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $113K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 2SEC | VIRVir Biotechnology, Inc. | Sell Plan | 37961,902 held (−1%) | $9.45 | $4K | +23.8% |
| Mar 24SEC | VIRVir Biotechnology, Inc. | Sell Plan | 7,71161,902 held (−11%) | $9.12 | $70K | +28.3% |
| Feb 26SEC | VIRVir Biotechnology, Inc. | Sell Plan | 1,43069,613 held (−2%) | $9.53 | $14K | +22.8% |
| Feb 24SEC | VIRVir Biotechnology, Inc. | Sell Plan | 1,82971,043 held (−3%) | $7.45 | $14K | +57.0% |
| Feb 18SEC | VIRVir Biotechnology, Inc. | Sell Plan | 1,53047,872 held (−3%) | $7.79 | $12K | +50.2% |
- Sell
Svp, Chief Accounting Officer Brent Sabatini sold $4K of VIR at $9.45 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp, Chief Accounting Officer Brent Sabatini sold $70K of VIR at $9.12 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp, Chief Accounting Officer Brent Sabatini sold $14K of VIR at $9.53 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp, Chief Accounting Officer Brent Sabatini sold $14K of VIR at $7.45 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp, Chief Accounting Officer Brent Sabatini sold $12K of VIR at $7.79 — pre-scheduled 10b5-1 plan sale.